INTRODUCTION
HISTORY
MAIN LEADERS
DEPARTMENTS
SPECIALISTS
RESEARCH
EDUCATION
PREVENTION
HONOUR
INTERNATIONAL
 You are here: Home >specialists>  Xiaofei Sun
 Professor  Xiaofei Sun

Mail address:
651 Dongfeng Road East
Guangzhou 510060
P.R.China
Phone: 86-20-87343364,87343598
Fax: 86-20-87343535
E-mail: gzsunxf@yahoo.com.cn

Education and Training Experience
Xiaofei Sun was graduated from Medical college of Sun Yat-Sen University in November 1982 and got a Bachelor of Medicine. After graduation, she worked as pediatrist in the affiliated third hospital of Sun Yat-Sen University in 1982-1986. She continued with her post-graduate training at Sun Yat-Sen University in 1986-1989 and got a master’s degree of pediatric hematology. She subsequently works at cancer center of Sun Yat-Sen University as attending doctor, associated professor and now as professor of department. of medical oncology. In 1995-1996, she spent one year at Department of Pediatrics, Aichi Medical University in Japan, as a visiting fellow. In 2000, she also went on to take a short term study in Hematology/Oncology Unite, Department of Pediatrics of Hong Kong University.

Research and Professional Experience
Dr Sun’s research is focused on developing molecular, prognostic and therapeutic approaches to improve the care for pediatric and adolescent patients with lymphoma, leukemia and solid tumor, specifically in lymphoma treatment. She set up the first pediatric medical oncology unite in the cancer centers in China and adopting international standard treatment strategy and protocols for pediatric and adolescent patients with cancer. Dr Sun is a member of the International Society of Paediatric Oncology (SIOP) and a commissary for Committee Pediatric Oncology in Chinese Anticancer Association and vice chairman of Committee Pediatric Oncology in Anticancer Association of Guangdong Province. She is manuscript reviewer of Chinese Journal of Clinic Oncology and member of the editorial board of Journal of Pediatric Oncology.

Publications (2000-2007)
 1. Sun Xiao-Fei, et al. Improved outcome of Chinese Children and Adolescents with
Lymphoblastic Lymphoma treated by modified BFM-90 regimen. Chinese Journal of Oncology. 2007,29(1): 58-61
 2. Ling Jia-yu, Sun Xiao-fei, et al Analysis of Immunophenotype of Bone Marrow in 112 Patients with Lymphoid System Malignant Diseases by Using Multiparameter Flow Cytometry.
Chinese Journal of Cancer, 26(4): 418-
 3. Zhen Zijun, Sun Xiaofei, et al. Feasibility to Treat Pediatric Cancer Pain with Analgesics for Adults and Their Efficacy. Chinese Journal of Cancer, 2007,26(8): 866-869
 4. Sun Xiao-Fei, et al Efficacy of Modified B-NHL-BFM-90 Protocol on Treatment of Burkitt’s Lymphoma in Chinese Children and Adolescents. Chinese Journal of Cancer, 26 (12): 1339
-1343
 5. Xiaofei Sun, et al. Improved treatment outcome in Chinese children and adolescents with Burkitt’s lymphoma and large cell lymphoma by using the modified B-non-Hodgkin’s lymphoma-Berlin-Frankfurt-Mu¨nster-90 protocol Eur J Haematol 2006: 77: 365–371
 6..Sun Xiaofei, et al. Analysis of Treatment Outcome in 44 Cases of Children and Adolescence Extracranial Germ Cell Tumor. Chinese Journal of Cancer, 2006,25(12):1529
 7..Sun Xiaofei, et al. The Clinical Features of B Cell Lymphoblastic Lymphoma and Outcomes after BFM-90 Regimen Therapy. Chinese Journal of Hemotology. 2006, 27(10).649-
 8. Wang Zhi Hui, Sun Xiao-Fei, et al. Effect of Preoperative Chemotherapy on Resection Rate of 54 Advanced Neuroblastoma Patients. Chinese Journal of Clinic Oncology. 2006,33(10):580-582
 9. Zhen Zijun, Sun Xiaofei, et al. Clinical Analysis of Reactive Thymic Hyperplasia Following Chemotherapy for Childhood Malignant Lymphoma. Chinese Journal of Cancer 2006,25(4):471~475
 10. Zhen Zijun, Sun Xiaofei, et al. Efficacy Chemotherapy Regimen Using Ifosphamide and Carboplatin on Recurrent or Refractory Neuroblastoma. Chinese Journal of Cancer, 2006, 25(12):1550-1552
 11.Wang Zhi Hui, Sun Xiao-Fei,et al. Clinical Significance of Serum Level of VEGF in Patients with Advanced Neuroblastoma. Chinese Cancer .2006,15(5):322-324
 12. Sun Xiaofei, et al Diagnosis and Treatment of Primary Central Nervous System Germ Cell Tumors. Chinese Journal of Neuro-oncology . 2006, 4: 272
 13. Tang Jing-yan,Xu Min, Wang Chang-lin, Sun Xiao-fei, et al. Preliminary Results of WT-2003 Wilms’ Tumor Protocol by the Chinese Pediatric Oncology Society. Chinese Journal of Pediatric Surgery 2006, 27(6)281-284.
 14. Sun Xiaofei,et al. Short-Term and Intensive Chemotherapy is Efficacious Treatment for Children and Adolescence with B Cell Non-Hodgkin’s Lymphoma. Chinese Journal of Hemotology. 2005, 10(4)
 15. Sun Xiaofei, et al. Comparing CHOP, CHOP+HD-MTX with BFM-90 Regimen in the Survival Rate for Childhood and Adolescence with B Cell Non-Hodgkin’s Lymphoma. Chinese Journal of Cancer 2004; 23(8): 933-938
 16. Sun Xiaofei, et al. Efficacy of Modified BFM-90 Regimen On Children and Adolescents with T cell Lymphoblastic Lymphoma: A report of 20 Case. Chinese Journal of Cancer 2004; 23(12):102-106
 17. Xia Yi, Sun Xiaofei et al. Primary Study of Relationship between Serum Level of VEGF and Non-Hodgkin’s Lymphoma in Children and Adolescent patients. Chinese Journal of Cancer. 2004,23(11s):88-90
 18. Sun Xiaofei, et al. Treatment of small non-cleaved-cell lymphoma and diffuse large B cell lymphoma by using modified CODOX-M/IVAC regimen. Chinese Journal of Cancer 2003; 22(4): 428-429
 19. Sun Xiaofei, et al. The Value of Multiparameter Flow Cytometry in Diagnosis of Lymphocytic Leukemia and Bone Marrow Involvement of Non-Hodgkin’s Lymphoma. Chinese Journal of Cancer 2003; 22(11): 1232-1236.
 20.. Sun Xiaofei, et al. Evaluation of Efficacy of Treatment for 30 cases of Children with Neuroblastoma. Chinese Journal of Cancer 2003; 22(12): 1343-1345
 21. Sun Xiaofei.. Treatment of primary intracranal germ cell tumor. Chinese Journal of Neuro-oncology 2003,1(4) 257-259
 22. Sun Xiaofei, et al. Long Term Effect of Children and Adolescence with Hodgkin’s Disease Treated with MOPP/ABVD. Chinese Cancer 2002; 11(4): 240-242
 23. Sun Xiaofei, et al. Clinical Study of rhIL-11 for Prevention and Treatment of Chemotherapy-Induced Thrombocytopenia. Chinese Journal of Cancer 2002; 21(8): 892~895
 24. Sun Xiaofei, et al . Comparing CVDLP with CHOP in induction treatment for patients with advanced lymphoblastic lymphoma. Chinese Journal of Cancer 2001; 20(4): 403~405
 25. Sun Xiaofei, et al .Treatment of high grade Non-Hodgkin’s lymphoma.Chinese Journal of Cancer 2001; 20(8): 891~893
 26. Sun Xiaofei, et al. Dectecting DNA content, cell cycle and Ki 67 expression in solid tumor by using FCM double labeling methods. Chinese Journal of Cancer, 2000;19(7):729-730
 27. Sun Xiaofei, et al . Clinical application of Ki67/DNA bivariate flow cytometry on solid tumor. Journal of Practical Oncology. 2000; (6): 385~387